Texas Womans University

Texas Woman's University, a state-controlled Hispanic-serving institution and minority institution based in Denton, Texas, receives federal research and education grants as a prime recipient (89% of awards) and participates in sub-recipient arrangements on research projects led by other universities and organizations. The institution does not hold federal contracts or IDVs; its federal footprint is entirely grant-based, spanning biomedical research, STEM education, student support services, and workforce development.

The university's customer base is concentrated in health, education, and agriculture agencies. The Department of Health and Human Services Health Resources and Services Administration leads by award count with 18 grants, followed by the Department of Education's Office of Postsecondary Education with 16 awards and the Department of Agriculture's National Institute of Food and Agriculture with 12 awards. The National Science Foundation and the National Institutes of Health each account for 7 awards. These five customer organizations represent approximately 35% of the institution's 171 total awards. Recent grant activity has declined — from 13 awards in 2022 to 5 awards in 2026 through September — a trajectory shift worth monitoring for pipeline and institutional capacity signals.

Texas Woman's University's research footprint centers on life sciences, nutrition, and health-related investigations. Recent representative grants include a $133,175 National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) project grant awarded September 2026 investigating DHRS9's role in diet-induced obesity and diabetes; a $292,496 Department of Agriculture Agriculture and Food Research Initiative (CFDA 10.310) award in August 2026 for developing rapid pathogen detection methods in food processing facilities; a $475,063 National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846) project grant from August 2026 examining vitamin A metabolism in hair follicle stem cell regulation; a $393,180 National Heart, Lung, and Blood Institute (CFDA 93.837) project grant awarded September 2024 developing an asthma self-management questionnaire for adolescents; and a $1.5 million National Science Foundation STEM Education project grant (CFDA 47.076) from January 2022 supporting scholarships and co-curricular activities in biotechnology. Education-focused grants include two concurrent $272,364 Department of Education TRIO Student Support Services awards (CFDA 84.042) effective September 2025 serving disadvantaged students in general and STEM pathways.

The institution acts as sub-recipient on research projects where faculty contribute as co-investigators or evaluation leads. Sub-award participation since 2021 includes a University of North Texas-led NASA research exchange project involving surface characterization and STEM student internships; a University of Texas at Arlington-led intervention study on cervical cancer in Black women; multiple University of Houston System grants on domestic violence and maternal health where a TWU faculty member contributes protocol oversight and participant recruitment expertise; a Duke University-led COVID-19 education study with TWU providing community engagement; and a Geneva Foundation-led project developing human-based laboratory models for hearing loss research.

Twelve awards face ultimate completion within the next twenty-four months, representing near-term recompete and renewal opportunities. The combined obligated dollars across all awards ($124.8 million) substantially exceed the combined potential value ($62 thousand), indicating the source data reflects a mix of completed, ongoing, and newly awarded grants where the majority of funding has already been obligated against older awards.